Publications PDF  | Print |  E-mail

PEER REVIEWED PUBLICATIONS

  1. Shurman DJ, Parker JN, Ornstein DK: Total condylar knee replacement: A study of factors influencing range of motion as late as two years after arthroplasty. JBJS, 67(7):1006, 1985.
  2. La Branche CC, Clark SC, Johnson DG, Ornstein DK, Sabath DE, Tushinski R, Paetkau V, Prystowsky MB: Deletion of carboxy-murine granulocyte-macrophage colony-stimulating factor results in a loss of biological activity and altered glycosylation. Arch Bioch Bioph., 276(1):153, 1990.
  3. Teichberg V, Eshar N, Maoz I, Mano I, Ornstein DK, Ortega A, Gregor P: Molecular characterization, ultrastructural localization and gene cloning of the chick cerebellar kainate receptor. Ad Exp Med Biol, 268: 1990.
  4. Ornstein DK, Dierks SM, Colberg JW: Metachronous presentation of bilateral leydig cell tumors. J Urol, 155: 1703, 1996.
  5. Ornstein DK, Rao GS, Johnson B, Charlton ET, Andriole GL: Combined finasteride and flutamide therapy in men with advanced prostate cancer. Urology, 48: 901, 1996.
  6. Ornstein DK, Rao GS, Smith DS, Basler JW, Ratliff TL, Catalona WJ: The effect of digital rectal examination and prostate biopsy on serum total and percentage of free prostate specific antigen. J Urol, 157: 195, 1997.
  7. Ornstein DK, Rao GS, Smith DS, Andriole GL: The impact of prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate. J Urol, 157: 880, 1997.
  8. Kawakita M, Rao GS, Ritchey JK, Ornstein DK, Hudson MA, Tartaglia J, Paoletti E, Humphrey PA, Harmon TJ, Ratliff TL: Effect of canarypox (ALVAC) virus mediated cytokine gene expression on prostate tumor growth. J Natl Cancer Inst, 89:428, 1997.
  9. Catalona WJ, Smith DS, Ornstein DK: Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/ml and benign prostate examination: Enhancement of specificity with free PSA measurements. JAMA, 277: 1452, 1997.
  10. Ornstein DK, Smith DS, Rao GS, Basler JW, Ratliff TL, Catalona WJ: Biological variation of total, free, and percentage of free serum prostate specific antigen in screening volunteers. J Urol, 157: 2179, 1997.
  11. Sotelo R, Ornstein DK, Rao G, Camacho R, Szemat R, Andriole GL: Renal tuberculosis presenting as a large perinephric mass. Infect Urol, 10: 171, 1997.
  12. Arcangeli GG, Ornstein DK, Keetch DK Andriole GL: PSA as a screening test for prostate cancer: the United States experience. Urol Clin North Am 24:299, 1997.
  13. Ornstein DK, Arcangeli GG, Andriole GL: Renal masses: urological management. MRI Clin North Am 5:1, 1997.
  14. Ornstein DK, Smith DS, Humphrey PA, Catalona WJ: Effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percent free serum prostate specific antigen levels in men without clinically detectable prostate cancer. J Urol 159: 1234, 1998.
  15. Ornstein DK, Smith DS, Andriole GL: Biochemical response to testicular ablation among prostate cancer patients failing flutamide and/or finasteride therapy. Urology, 52: 1094, 1998.
  16. Ornstein DK, Colberg JW, Virgo KS, Chan D, Johnson ET, Oh J, Johnson FE: Evaluation and management of men failing radical prostatectomy: results of an international survey. Urology, 52: 1047, 1998.
  17. Ornstein DK, Herschman JD, Oh J, Andriole GL: Evaluation and management of the man who has failed primary curative therapy of prostate cancer. Urol Clin North Am 25: 591, 1998.
  18. Ornstein DK, Beiser JA, Andriole GL: Anemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer. Brit J Urol, 83: 43, 1999.
  19. Oh J, Colberg JW, Ornstein DK, Johnson ET, Chan D, Virgo KS, Johnson FE: Current follow-up strategies after radical prostatectomy: a survey of AUA urologists. J Urol, 161: 520, 1999.
  20. Tsai, DY, Virgo KS, Colberg JW, Ornstein DK, Johnson ET, Chan D, Johnson FE: The age of the urologist affects the postoperative care of prostate carcinoma patients. Cancer, 86: 1314, 1999.
  21. Ornstein DK, Dahut WL, Liotta LA, Emmert-Buck MR: Review of AACR meeting: New research approaches in the prevention and cure of prostate cancer. Biochim Biophys Acta 1424:11, 1999.
  22. Naughton CK, Ornstein DK, Smith DS, Catalona WJ: Pain and morbidity of transrectal ultrasound-guided prostate biopsies: preliminary report of a prospective randomized trial comparing six versus twelve cores. J Urol, 163: 168, 2000.
  23. Ornstein DK, Lubensky IA, Venzon D, Zbar B, Linehan WM, Walther MM: Prevalence of microscopic tumors in normal appearing renal parenchyma from patients with hereditary papillary renal cancer. J Urol, 163: 431, 2000.
  24. Paweletz CP, Gillespie JW, Ornstein DK, Simone NL, Cole KA, Yip TT, Hutchens TW, Linehan WM, Weber T, Emmert-Buck MR, Liotta LA, Petricoin EF: Tissue proteomics at the microscale: a novel approach to the study of disease progression. Drug Devlp Res 49: 34, 2000.
  25. Emmert-Buck MR, Gillespie JW, Paweletz CP, Ornstein DK, Basrur V, Appella E, Wang QH, Huang J, Hu N, Taylor P, Petricoin EF: An approach for proteomic analysis of microdissected human tumors. Molec Carcinog, 27: 158, 2000.
  26. Ornstein DK, Englert CR, Gillespie JW, Paweletz CP, Liotta LA, Linehan WM, Emmert-Buck MR, Petricoin EF: Characterization of intracellular prostate specific antigen from laser microdissected benign and malignant prostatic epithelium. Clin Cancer Res, 6: 353, 2000.
  27. Emmert-Buck MR, Strausber RL, Krizman DB, Bonaldo MF, Bonner RF, Bostwick DG, Brown MR, Buetow KH, Chuaqui RF, Cole KA, Duray PH, Englert CR, Gillespie JW, Greenhut S, Grouse L, Hillier LW, Katz KS, Klausner RD, Kuznetzov V, Lash AE, Lennon G, Linehan WM, Liotta LA, Marra MA, Munson PJ, Ornstein DK, Prabhu VV, Prange C, Schuler GD, Soares MB, Tolstoshev CM, Vocke CD, Waterson RH: Molecular profiling of clinical tissue specimens: Feasibility and applications. Amer J Path, 4: 1109, 2000.
  28. Johnson FE, Virgo KS, Ornstein, DK, Johnson ET, Chan D, Colberg JW: How tumor stage affects American urologists’ surveillance strategies after prostate cancer stage. Int J Oncol, 16: 1221, 2000.
  29. Powell TM, Thompsen JP, Virgo KS, Johnson ET, Chan D, Colberg JW, Ornstein DK, Johnson FE: Geographic variation in patient surveillance after radical prostatectomy. Ann Surg Oncol, 7: 339, 2000.
  30. Ornstein DK, Gillespie JW, Paweletz CP, Duray PH, Herring J, Vocke CD, Topalian SL, Bostwick DG, Linehan WM, Petricoin III EF, Emmert-Buck MR: Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis, 21: 2235, 2000.
  31. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ: A prospective randomized trial comparing six versus twelve prostate biopsy cores: impact on cancer detection. J Urol, 164: 388, 2000.
  32. Ornstein DK, Pruthi RS: Prostate-specific antigen. Exp Opin Pharmacother, 1: 1399, 2000.
  33. Paweletz CP, Ornstein DK, Roth M, Bichsel VE, Calvert VS, Wang QH, Hu N, Taylor P, Liotta LA, , Gillespie JW, Vocke CD, Hewitt SM, Duray PH, Herring J, Linehan WM, Emmert-Buck MR, Petricoin EF: Loss of annexin I correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res, 60: 6293, 2000.
  34. Paweletz CP, Gillespie JW, Ornstein DK, Simone NL,  Brown MR, Cole, KA, Quan-Hong Wang, Huang J, Hu N, Yip TT, Rich, WE, Kohn, EC, Linehan WM, Weber T, Taylor P, Emmert-Buck MR, Liotta LA, and Petricoin EF: Rapid Protein Display Profiling of Cancer Progression Directly From Human Tissue Using a Protein Biochip. Drug development research 49: 34-42, 2000.
  35. Thornbury JR, Ornstein DK, Choyke PL, Langlotz CP, Weinreb JC: Prostate cancer: What is the future role for imaging? Am J Roentgenol, 176: 17, 2001.
  36. Ornstein DK, Cinquanta M, Weiler S, Duray PH, Emmert-Buck MR, Vocke CD, Linehan WM, Ferretti JA: Expression studies and mutational analysis of the androgen regulated homeobox gene NKX-3.1 in benign and malignant prostate epithelium. J Urol, 165: 1329, 2001.
  37. Ornstein DK, Kang JS: How to improve prostate biopsy detection of prostate cancer. Curr Urol Rep, 2: 218, 2001.
  38. Kang JS, Calvo BF, Maygarden SJ, Caskey LS, Mohler JL, Ornstein DK: Dysregulation of annexin I protein expression in high grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res, 8: 117, 2002.
  39. Ahram M, Best CJM, Flaig MJ, Gillespie JW, Leiva IM, Chaqui RF, Zhou G, Shu H, Duray PH, Linehan WM, Raffeld M, Ornstein DK, Zhao Y, Petricoin EF, Emmert-Buck MR: Proteomic Analysis of Human Prostate Cancer. Molec Carcinog, 33: 9, 2002.
  40. Gaston KE, Ornstein DK: Pharmacotherapy for biochemical recurrences after therapy for localised prostate cancer. Expert Opin Pharmacother, 3: 657, 2002.
  41. Pruthi RS, Richman M, Ornstein DK: A case of T1C, N3, M1 prostate cancer. Urol Int, 69: 82, 2002.
  42. Petricoin EF, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, Hitt, BA, Velassco A, Trucco, C., Wiegand L, Wood K, Simone CB, Levine PJ, Linehan WM, Emmert-Buck MR, Steinberg SM, Kohn EC, Liotta LA: Serum proteomic patterns for the detection of prostate cancer. J Natl Cancer Inst, 16;9:1576, 2002.
  43. Ahram M, Flaig MJ, Gillespie JW, Duray PH, Linehan WM, Ornstein DK, Niu S, Zhoa Y, Petricoin EF, Emmert-Buck MR: Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications. Proteomics 3: 413, 2003.
  44. Smitherman AB, Mohler JL, Maygarden SJ, Ornstein DK: Expression of annexin I, II and VII in androgen-stimulated and recurrent prostate cancer. J Urol 171: 916, 2004.
  45. Ornstein DK, Petricoin EF: Proteomics to diagnose human tumors and provide prognostic information. Oncology 18: 521, 2004.
  46. Petricoin EF, Ornstein DK, Liotta LA: Clinical proteomics: Applications for prostate cancer biomarker discovery and detection. Urol Oncol Jul – Aug: 322, 2004.
  47. Ornstein DK, Rayford W, Fusara VA, Conrads TP, Ross SJ, Hitt BA, Wiggins WW, Veenstra TD, Liotta LA, Petricoin EF. Serum Proteomic Profiling Can Discriminate Prostate Cancer From Benign Prostates in Men With Total Prostate Specific Antigen Levels Within the “Diagnostic Grey Zone”. J Urol 172: 1302, 2004.
  48. Sala LG, Matsunaga GS, Corica FA, Ornstein DK. Robotic-Assisted Laparoscopic Radical Cystoprostatectomy and Totally Intracorporeal Ileal Neobladder: Initial Case Report. J Endourol 20: 233, 2006.
  49. Hsiang CH, Tsunoda T, Whang Y, Tyson DR, Ornstein DK. The Impact of Altered Annexin I Protein Levels On Apoptosis and Signal Transduction Pathways in Prostate Cancer Cells. Prostate 66: 1413, 2006.
  50. Ornstein DK, Tyson DR. Proteomics For The Identification of New Prostate Cancer Biomarkers. Urol Oncol, 24: 231, 2006.
  51. Yee D, Narula, N, Ramzy, I, Boker J, Ahlering TA, Skarecky D and Ornstein DK. Reduced Annexin II Protein Expression in High Grade Prostatic Intraepithelial Neoplasia and Prostate Cancer. Arch of Path & Lab Med 131: 902, 2007.
  52. Finley DS, Melamud O, Ornstein DK. Combined Robotic-Assisted Nephroureterectomy and Radical Prostatectomy. J Endourol 21: 411, 2007.
  53. Young JL, Finley DS, Ornstein DK. Robotic Assisted Laparoscopic Cystoprostatectomy for Prostatic Carcinsarcoma: The First Report. J Soc Laparoendo Surg. 11: 109, 2007.
  54. Abraham JB, Young JL, Box GN, Lee HJ, Deane LA, Ornstein DK. Comparative Analysis of Laparoscopic and Robotic-Assisted Radical Cystectomy With Ileal Conduit Urinary Diversion. J Endourol. 21: 1473, 2007.
  55. Tyson DR, Inokuchi J, Tsunoda T, Lau A, Ornstein DK. Culture requirements of Prostatic Epithelial Cell Lines for Acinar Morphogenesis and Lumen Formation In Vitro: Role of Extracellular Calcium. The Prostate 67: 1601, 2007.
  56. Finley DS, Deane L, Rodriguez E, Vallone J, Deshmukh S, Skarecky D, Carpenter P, Narula N, Ornstein DK, Ahlering TE. Anatomic Excision of Anterior Prostatic Fat at Robotic Radical Prostatectomy: Implications for Pathologic Upstaging. Urology 70: 1000, 2007.
  57. Deane LA, Lee HJ, Box GN, Melamud O, Yee DS, Abraham BA, Borin JF, McDougall EM, Clayman RV, Ornstein DK. Robotic versus Standard Laparoscopic Partial/Wedge Nephrectomy: A Comparison of Intra- and Peri-Operative Results From a Single Institution. J Endourol. 22: 1,2008.
  58. Liss M, Osann K, Ornstein DK, Positive Surgical Margins During Robotic Radical Prostatectomy: A Contemporary Analysis of Risk Factors. BJU Int. 102: 603, 2008.
  59. Yee DS, Ornstein DK. Repair of Rectal Injury During Robotic Assisted Laparoscopic Prostatectomy. Urology 72: 428, 2008.
  60. Tyson DR, Ornstein DK. Proteomics of Cancer of Hormone-Dependent Tissues. Adv Exp Med Biol. 630: 133, 2008.
  61. Inokuchi J, Narula N, Yee DS, Skarecky DW, Lau A, Ornstein DK. Annexin A2 Positively Contributes to the Malignant Phenotype and Secretion of IL-6 in DU145 Prostate Cells. Int J Cancer. 124: 68, 2009.
  62. Phillips JM, Narula N, Deane LA, Box GN, Lee HJ, Ornstein DK, McDougall EM, Clayman RV. Histologic Evaluation of Cold Versus Hot Cutting: Clinical Impact on Margin Status for Laparoscopic Partial Nephrectomy. J Urol. {epub} 2008.
  63. Gamboa AJ, Santos RT, Sargent ER, Louie MK, Box GN, Sohn KH, Truong H, Lin R, Khonsravi A, Santos R, Ornstein DK, Ahlering TE, Tyson DR, Clayman RV, McDougall EM. Long-Term Impact of a Robot Assisted Laparoscopic Prostatectomy Mini Fellowship Training Program on Post-Graduate Urologic Practice Patterns. J Urol. {epub} 2008.
  64. Kalisvaart JF, Finley DS, Ornstein DK. Robotic-Assisted Repair of Iatrogenic Ureteral Ligation Following Robotic-Assisted Hysterectomy. J Soc Lapro Endo Surg. 12: 414, 2008.
  65. Gamboa AJ, Young JL, Dash A, Abraham JB, Box GN, Ornstein DK. Pelvic Lymph Node Dissection and Outcome of Robot-Assisted Radical Cystectomy for Bladder Carcinoma. J Robotic Surgery (in press)
  66. Inokuchi J, Lau A, Tyson DR, Ornstein DK. Loss of Annexin A1 Disrupts Normal Prostate Glandular Structure by Inducing Autocrine IL-6 Signaling. Carcinogenesis 30: 1082, 2009.
  67. Tsunoda T, Furusato B, Takashima Y, Ravulapalli S, Dobi A, Srivastava S, McLeod DG, Sesterhenn IA, Ornstein DK, Shirasawa S. The Increased Expression of Periostin During Early Stages of Prostate Cancer and Advanced Stages of Cancer Stroma. Prostate 15: 1398, 2009.
  68. Finley DS, Calvert VS, Inokuchi J, Lau A, Narula N, Petricoin EF, Zaldivar F, Santos R, Tyson DR, Ornstein DK. Periprostatic Adipose Tissue As a Modulator of Prostate Cancer Aggressiveness. J Urol {Epub ahead of print} 2009

BOOK CHAPTERS

  1. Ornstein DK, Andriole GL: Screening for prostate cancer in 1999. AUA Update Series Lesson 1, Volume XVII, 1999.
  2. Miller DC, Ornstein DK, Andriole GL: Screening for prostate cancer: an overview. In: Resnick MI, Thompson IM eds. Advanced Therapy, Prostatic Disease. Ontario, Canada: B.C. Becker Inc., 50 – 59, 2000.
  3. Ornstein DK, Velasco A, Andriole GL: PSA and Early Detection. In: Brawer M eds. Prostate Specific Antigen, New York: Merkel Dekker, Inc. 137 – 157, 2001.
  4. Walther MM, Leach F, Ornstein DK, Zambrano N, Linehan WM: Genitourinay malignancy: etiology and molecular genetics, natural history and treatment. In Gillenwater J, Grayhack J, Howards S, Mitchell M eds. Adult and Pediatric Urology, 4th edition, Philadelphia: Lippincott, Williams and Wilkins, Inc. 319 – 353, 2002.
  5. Ashkin E, Ornstein D: Selected Disorders of the Genitourinary Tract. In: Taylor RB, editor. Family medicine: principals and practice, 6th ed. New York: Springer-Verlag, 2003.
  6. Ornstein DK, Andriole GL: Renal cancer: presentation, diagnosis & staging. In: Hamby: Management of Urologic Malignancies. London: U.K. Harcourt Brace & Company Ltd. 2002.
  7. Year Book of Urology 2002. contributor to Chp 4 Renal Tumors, Chp 14 Testes Cancer and Chp 15 Penile Cancer. Editors Gerald L. Andriole and Douglas E. Coplen. St. Louis, Mosby, 2002.
  8. Ratliff TL, Kawakita M, Rao G, Ornstein DK: Gene therapy in urology: a new era. In: Abi-Aad AS eds. Adjuvant Treatment in Urological Cancer: Parthenon (in press)
  9. Duray PH, Ornstein DK, Vocke CD, Hewitt S, Cole KA, Gillespie JW, Englert CR, Petricoin EF, Krizman DB, Linehan WM, Emmert-Buck MR: Genetic alterations in prostatic intraepithelial neoplasia (PIN). (in press)
  10. Kim IY, Ornstein DK: Clinical Utilities of Microdissected Samples. In: Emmert-Buck MR, Gillespie JW, Chuqui RF editors. Dissecting The Molecular Anatomy of Tissue. New York: Springer-Velag, 2004.
 
 
© 2008 DavidOrnsteinMD. All rights reserved